Well Referenced

Tag: neurotransmitter modulation

Cellular and molecular actions of Methylene Blue in the nervous system

Methylene blue (MB) has demonstrated potential therapeutic benefits in neuroprotection, mood disorders, and neurodegenerative diseases such as Alzheimer’s. This review highlights MB’s mechanisms of action, including its inhibition of monoamine oxidase A (MAO-A), which increases serotonin and dopamine levels, and its modulation of the cyclic guanosine monophosphate (cGMP) pathway, which

Read More »
June 26, 2025 No Comments

Methylene blue and its analogues as antidepressant compounds

This review explores the antidepressant and anxiolytic properties of methylene blue (MB) and its analogues. MB exerts its effects through mechanisms such as monoamine oxidase A (MAO-A) inhibition, which increases neurotransmitter levels, and modulation of nitric oxide pathways. These actions suggest MB’s potential as a therapeutic agent for treating mood

Read More »
June 26, 2025 No Comments

An update on emerging drugs for the treatment of erectile dysfunction

This review discusses emerging therapies for erectile dysfunction (ED), including centrally and peripherally acting agents and regenerative medicine approaches such as stem cell therapy and platelet-rich plasma injections. These novel treatments target neurotransmitter pathways, vascular function, and tissue regeneration, potentially benefiting patients unresponsive to existing therapies. While promising, these therapies

Read More »
June 26, 2025 No Comments